These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8321759)
21. Effect of the combination of low-dose mexiletine and metoprolol on ventricular arrhythmia. Ravid S; Lampert S; Graboys TB Clin Cardiol; 1991 Dec; 14(12):951-5. PubMed ID: 1726725 [TBL] [Abstract][Full Text] [Related]
22. The analgesic effect of gabapentin and mexiletine after breast surgery for cancer. Fassoulaki A; Patris K; Sarantopoulos C; Hogan Q Anesth Analg; 2002 Oct; 95(4):985-91, table of contents. PubMed ID: 12351281 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of mexiletine in the medium-term treatment of ventricular arrhythmias. A randomized, double-blind, crossover trial against placebo in ambulatory patients. Masotti G; Morettini A; Casolo GC; Ieri A; Zipoli A; Serneri GG J Int Med Res; 1984; 12(2):73-80. PubMed ID: 6202571 [TBL] [Abstract][Full Text] [Related]
24. Mexiletine. Long-term efficacy and side effects in patients with chronic drug-resistant potentially lethal ventricular arrhythmias. Kerin NZ; Aragon E; Marinescu G; Faitel K; Frumin H; Rubenfire M Arch Intern Med; 1990 Feb; 150(2):381-4. PubMed ID: 2302013 [TBL] [Abstract][Full Text] [Related]
25. Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias. Kim SG; Mercando AD; Tam S; Fisher JD J Am Coll Cardiol; 1989 Mar; 13(3):659-64. PubMed ID: 2918173 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of oral mexiletine therapy at a 12-h dosage interval. Steen SN; Hughes EM; Sharon G; MacGregor TR Chest; 1990 Feb; 97(2):358-63. PubMed ID: 1688758 [TBL] [Abstract][Full Text] [Related]
28. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation. Kim SG; Felder SD; Waspe LE; Fisher JD Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of disopyramide and mexiletine used alone or in combination in the treatment of ventricular premature beats. Sakurada H; Motomiya T; Hiraoka M Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():835-41. PubMed ID: 1718397 [TBL] [Abstract][Full Text] [Related]
37. The use of oral mexiletine for the treatment of pain after peripheral nerve injury. Chabal C; Jacobson L; Mariano A; Chaney E; Britell CW Anesthesiology; 1992 Apr; 76(4):513-7. PubMed ID: 1312797 [TBL] [Abstract][Full Text] [Related]
38. The effects of mexiletine on excitability properties of human median motor axons. Kuwabara S; Misawa S; Tamura N; Kanai K; Hiraga A; Ogawara K; Nakata M; Hattori T Clin Neurophysiol; 2005 Feb; 116(2):284-9. PubMed ID: 15661106 [TBL] [Abstract][Full Text] [Related]
39. Lidocaine and mexiletine therapy for erythromelalgia. Kuhnert SM; Phillips WJ; Davis MD Arch Dermatol; 1999 Dec; 135(12):1447-9. PubMed ID: 10606048 [No Abstract] [Full Text] [Related]
40. [Mexiletine in treatment of painful diabetic neuropathy]. Stracke H; Meyer U; Schumacher H; Armbrecht U; Beroniade S; Buch KD; Federlin K; Haupt E; Husstedt IW; Kampmann B Med Klin (Munich); 1994 Mar; 89(3):124-31. PubMed ID: 8196572 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]